FDA Issues Safety Alert for Bioprosthetic Aortic Valves Because of Reduced Leaflet Motion
In a safety alert issued on October 5, the Food and Drug Administration (FDA) noted recent reports of reduced leaflet motion in some bioprosthetic aortic valves, including both SAVR (surgical [...]